POISE-3 Backs Wider Use of TXA in Noncardiac Surgery - Medscape
4/2/2022 12:00:00 AM3 years 11 months ago
by Patrice Wendling and Catherine Hackett
by Patrice Wendling and Catherine Hackett
The antifibrinolytic tranexamic acid (TXA) reduced serious bleeding without a significant effect on major vascular outcomes in patients undergoing noncardiac surgery at risk for these complications i… [+8861 chars]
full article...